Donor CD34+

Investigated by: California Institute for Regenerative Medicine (CIRM) · Northwestern University · Stanford University

today NCT03943238 · Ph 1

20202021202220232024202520262027202820292030

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT03943238	Feb 2020 → Nov 2029 expected	—	Stanford University	Recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Donor CD34+	“an infusion of purified donor CD34+” NCT03943238 ↗